GRK2 and heart failure: Some experiments suggest that diminished GRK2 activity may act synergistically with β-blocker therapeutic drugs to prevent mortality risk in individuals with heart failure (Najafi et al., 2016; Schumacher et al., 2015; Lymperopoulos et al., 2013; Cannavo et al., 2013).